Results 251 to 260 of about 57,339 (296)
Some of the next articles are maybe not open access.
Myocardial Bridging in a Man With Non–ST-Elevation Myocardial Infarction
Circulation, 2015A 75-year-old man with hyperlipidemia was admitted with substernal chest tightness associated with an elevated cardiac-specific troponin. He had experienced symptoms of an upper respiratory tract infection with fever, cough, and decreased oral intake over the previous 2 weeks.
Brian A, Bergmark +3 more
openaire +2 more sources
Management of non–ST-Segment Elevation Myocardial Infarction
Medical Clinics of North America, 2007Non-ST-segment elevation myocardial infarction (NSTEMI) is a major cause of cardiovascular morbidity and mortality in the United States. It represents the highest risk category of non-ST-segment elevation acute coronary syndromes (NSTEACS), for which timely diagnosis and appropriate therapy are paramount to improve outcomes.
Stephen E, Van Horn, Calin V, Maniu
openaire +2 more sources
Timing of angiography in non-ST elevation myocardial infarction
Heart, 2013Acute chest pain remains one of the most difficult challenges for the clinician. Nowadays, chest pain and its related complaints account for up to 10% of the adult emergency admissions and around 25% of all hospital admissions.w1 Notably, the number of patients presenting with complaints of chest pain is rising.w2 In a typical population of patients ...
Riezebos, R.K., Verheugt, F.W.A.
openaire +3 more sources
Revascularization Strategies for Non-ST-Elevation Myocardial Infarction
Current Cardiology Reports, 2019Non-ST-elevation myocardial infarction (NSTEMI) is an urgent medical condition that requires prompt application of simultaneous pharmacologic and non-pharmacologic therapies. The variation in patient clinical characteristics coupled with the multitude of treatment modalities makes optimal and timely management challenging.
Bennet, George +2 more
openaire +2 more sources
Bad medicine: non-ST elevation myocardial infarction
BMJ, 2013No one ever got sued for doing too much. Accordingly, 60% of the UK patients prescribed statins are considered at low risk—that is, they do not need treatment.1 2 But doctors are treating cholesterol concentrations. No one is interested in the abstract concept of risk. It’s easier to do something than nothing. However, while a diagnosis may last only a
openaire +2 more sources
Unstable Angina and Non–ST Elevation Myocardial Infarction
American Journal of Respiratory and Critical Care Medicine, 2012Abstract Non–ST elevation acute coronary syndromes are responsible for approximately 1 million admissions to U.S. hospitals and twice as many to European hospitals each year. Thus, they are among the most common serious illnesses in adults, and are associated with an in-hospital mortality of approximately 5%.
openaire +2 more sources
The delayed activation wave in non-ST-elevation myocardial infarction
International Journal of Cardiology, 2013Little is known about the relationship between the electrocardiographic characteristics and the infarct related artery (IRA) in non-ST-elevation myocardial infarction (NSTEMI). We found a curious phenomenon in electrocardiograms of patients with acute occlusion of left circumflex artery in NSTEM: A notch or deflection was often present in the terminal ...
Tiesheng, Niu +9 more
openaire +2 more sources
Unstable angina and non-ST-segment elevation myocardial infarction
Current Treatment Options in Cardiovascular Medicine, 2002In the last 20 years there have been enormous advances in our understanding of the acute coronary syndromes and how to manage patients presenting with them. In the 1980s, we began to understand the importance of thrombus formation was in the pathophysiology of acute coronary syndromes.
John A., Ambrose, Zaheed, Tai
openaire +2 more sources
Journal of Electrocardiology, 2005
0022-0736/$ – see fro doi:10.1016/j.jelectroc T Corresponding Fig. Thrombolytic therapy has been increasingly employed in acute ST-elevation myocardial infarction. Rapid thrombolytic administration and cardiac catheterization have been shown to decrease mortality. However, the risk of major bleeding requires the judicious administration of such therapy.
Casey S, Hager, William H, Carter
openaire +2 more sources
0022-0736/$ – see fro doi:10.1016/j.jelectroc T Corresponding Fig. Thrombolytic therapy has been increasingly employed in acute ST-elevation myocardial infarction. Rapid thrombolytic administration and cardiac catheterization have been shown to decrease mortality. However, the risk of major bleeding requires the judicious administration of such therapy.
Casey S, Hager, William H, Carter
openaire +2 more sources